In vivo brain myo-inositol levels in children with Down syndrome

Journal of Pediatrics

Volumn 135, Issue 1, 1999, Pages 94-97

  Berry, Gerard T ^a,b,c   Wang, Zhiyue J ^a,b   Dreha, Steffi F ^a,b   Finucane, Brenda M ^a,b   Zimmerman, Robert A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Elwyn   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL;

ADOLESCENT; ARTICLE; BRAIN GANGLION; BRAIN LEVEL; CHILD; CHROMOSOME 21Q; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORPUS STRIATUM; DOWN SYNDROME; FEMALE; HUMAN; MALE; OSMOREGULATION; PLASMA OSMOLALITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TRISOMY 21;

EID: 0033498243     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70334-3     Document Type: Article

References (20)

1. 1. Epstein CJ. Down syndrome (trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill; 1995. p. 749-94.
2. 2. Fruen BR, Lester BR. Down's syndrome fibroblasts exhibit enhanced inositol uptake. Biochem J 1990;270:119-23.
3. +/myo-inositol cotransporter gene: molecular cloning and localization to chromosome 21. Genomics 1995;25:507-13.
4. +/ myo-inositol cotransporter (SLC5A3) gene. Cytogenet Cell Genet 1996;73: 77-8.
5. +/myo-inositol cotransporter (SLC-5A3) gene and characterizations of the promoter. Genomics 1997;46:459-65.
6. 6. Rim JS, Atta MG, Dahl SC, Berry GT, Handler JS, Kwon HM. Transcription of tne sodium/myo-inositol cotransporter gene is regulated by multiple tonicity-responsive enhancers spread over 50 kilobase pairs in the 5′-flanking region. J Biol Chem 1998; 273:20615-21.
7. 7. Berridge MJ, Irvine RF. Inositol phosphates and cell signaling. Nature 1989;341:197-205.
8. 8. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988;334:661-5.
9. 9. Toker A, Cantley LC. Signaling through lipid products of phosphoinositide-3OH kinase. Nature 1997;387:673-6.
10. 10. Carpenter CL. Intracellular signals cytoskeleton: the interactions of phosphoinositide kinases and small G proteins in adherence, ruffling and motility. Cell Dev Biol 1996;7:691-7.
11. 11. Provencher SW. Estimation of metabolite concentration from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-9.
12. 12. Michaelis T, Merboldt K-D, Bruhn H, Hanicke W, Frahm J. Absolute concentration of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-27.
13. 13. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentration. J Magn Reson 1993;102:9-19.
14. 14. Lee JH, Arcinue E, Ross BD. Organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med 1994;331-.439-42.
15. 15. Thurston JH, Sherman WR, Hauhart RE, Kloepper RF. Myo-inositol: a newly identified nonnitrogenous osmoregulatory molecule in mammalian brain. Pediatr Res 1989;26:482-5.
16. 16. Shonk T, Ross BD. Role of increased cerebral myo-inositol in the dementia of Down syndrome. Magn Reson Med 1995;33:858-61.
17. 17. Frahm J, Hanefeld F. Localized proton magnetic resonance spectroscopy of cerebral metabolites. Neuropediatrics 1996;27:64-9.
18. 18. Shetty HU, Holloway HW, Acevedo LD, Galdzicki Z. Brain accumulation of myo-inositol in the trisomy 16 mouse, an animal model of Down's syndrome. Biochem J 1996;313:31-3.
19. 19. Acevedo LD, Holloway HW, Rapoport SI, Shetty HU. Application of stable isotope tracer combined with mass spectrometric detection for studying myo-inositol uptake by cultured neurons from fetal mouse: effect of trisomy 16. J Mass Spectrom 1997; 32:595-400.
20. 20. Shetty HU, Schapiro MB, Holloway HW, Rapoport SI. Polyol profiles in Down syndrome. MI specifically is elevated in the cerebrospinal fluid. J Clin Invest 1995;95:542-6.